Study 200195 App
Developer: GlaxoSmithKline PLC
App Size: 52.35 MB
Release Date: 2018-04-25
Price: Free
Medical »
Study 200195 App
Screenshots for App
iPhone
iPad
More Screenshots for iPad
Study 200195 App’s purpose is to support GSK Study 200195 (Adenosine Deaminase Severe Combined Immunodeficiency (ADA-SCID) Registry for Patients Treated with Strimvelis™ (or GSK269273) Gene Therapy: Long-Term Prospective, Non-Interventional Follow-up of Safety and Effectiveness). Registry participant’s will be able to use the app to enter the required information for the study.
Study 200195 App 1.0 Update
2018-04-25 Version History
This app has been updated by Apple to display the Apple Watch app icon.
~GlaxoSmithKline PLC
~GlaxoSmithKline PLC
More Information about: Study 200195 App
Price:
Free
Version:
1.0
Compatibility:
Requires 9.0 or later
Bundle Id:
com.gsk.study200195
Size:
52.35 MB
Genre:
Medical
Release Date:
2018-04-25
Last Update:
2018-04-25
Content Rating:
12+
Developer:
GlaxoSmithKline PLC
Language:
EN -
All Apps & Games Created by: GlaxoSmithKline PLC
Related Apps
GeView
Latest Apps & Games
